Canadian Medical Marijuana & Cannabis Industry News

British Columbia, Quebec lead Canada’s marijuana sales higher in May

Canada’s adult-use cannabis sales jumped 14% in May on the back of new store openings in British Columbia and Ontario as well as longer store hours in Quebec – three markets that account for about three-quarters of the country’s consumers. Across the country, sales improved to 85 million Canadian dollars ($65 million) in May, up […]

Read More

Deal Watch: Big players are behind marijuana M&A deals

Last week wasn’t the busiest for completed M&A deals in the cannabis industry, but some notable transactions were concluded – including one involving a well-established multistate operator (MSO) and another a relatively new but fast-emerging player on the scene.

Read More

Aurora sole winner of Italian medical cannabis tender, but average price is low by most standards

Aurora Deutschland – the German subsidiary of Alberta-based Aurora Cannabis – won all three “lots” to supply Italy with a total of 400 kilograms (880 pounds) of medical marijuana over two years, the Italian government announced. But the award may come at a cost for the Canadian company: The average price it offered – 1.73 euros […]

Read More

Cannabis firm Valens beats expectations with CA$8.8 million quarterly revenue

Valens GroWorks’ revenue shot up nearly threefold to 8.8 million Canadian dollars ($6.7 million) in the last fiscal quarter on strong demand for its white-label services ahead of Canada’s infused cannabis market launch later this year. The revenue was ahead of analyst expectations. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) came in at […]

Read More

Canadian marijuana firm Organigram reports improved quarterly revenues, net loss

Organigram, a Canadian cannabis producer that trades on a major U.S. exchange, reported net revenues of 24.8 million Canadian dollars ($18.6 million) for the fiscal third quarter ended May 31, up from CA$3.44 million in the same period last year. Net loss for the quarter for the New Brunswick-based company was CA$10.2 million, compared with […]

Read More

Week in Review: CannTrust’s cannabis regulatory woes, Florida MMJ caps, push for Congress’ support of STATES Act & more

CannTrust is zapped by Health Canada for unlicensed cannabis cultivation, Florida’s medical marijuana license caps and vertical integration regulations are ruled unconstitutional, marijuana advocates urge a U.S. Congressional panel to support states-rights marijuana legislation – plus more of the week’s top marijuana business headlines. Bad week for Canadian marijuana grower Ontario company CannTrust was hit […]

Read More

Health Canada completes 75% of promised ‘high-level reviews’ of cannabis applications

Since overhauling the federal cannabis license application process in May, Health Canada completed about three-quarters of the eligible high-level reviews in the licensing queue as of the end of June. But some industry sources say the regulatory agency is not moving fast enough. As of May 8, Health Canada started requiring new cannabis cultivation applicants […]

Read More

Embattled CannTrust halts marijuana sales; Canada’s supply shortfall could worsen

CannTrust Holdings halted all sales of cannabis products while Canada’s federal regulator inspects its Vaughan, Ontario, manufacturing facility. The Ontario company received a “noncompliant” rating earlier this week from Health Canada for operating five unlicensed rooms. That means CannTrust’s 72,000 registered medical cannabis patients will have to look to other producers to fill their orders, likely […]

Read More

Canadian retailer pulls CannTrust’s recreational marijuana goods from shelves

Embattled Canadian cannabis cultivator CannTrust was dealt another blow after its recreational products were yanked from the shelves of Canada’s largest marijuana retailer. Daffyd Roderick, director of communications for the Ontario Cannabis Store (OCS), the province’s online retailer and wholesale distributor, confirmed to BNN Bloomberg that CannTrust’s products weren’t available for sale. “Due to the […]

Read More